Coenzyme Q10 shows potential benefitsProof of concept of the WOMED model of benign thyroid disease: Restitution of thyroid morphology after correction of physical and psychological stressors and magnesium supplementation.
Most Relevant Research
We explored the effects of a combination of magnesium, selenium, and coenzyme Q10 on the thyroid morphology in patients suffering from benign thyroid diseases, specifically looking at both hyperthyroidism and hypothyroidism. Our study involved 8 patients who received standard pharmacological treatment but also underwent additional therapy at our private institution.
Over a period of 2 to 4 years, we observed some remarkable changes. Initially, we addressed musculoskeletal issues and psychological stressors in our patients. Following this, thyroid morphology started to normalize, with improvements visible through ultrasound imaging. Notably, thyroid antibody levels declined in most patients, suggesting a positive response to the treatment.
However, it's essential to highlight that we could not assess the isolated impact of coenzyme Q10 on hypothyroidism specifically, as it was part of a broader treatment regimen. While we saw promising results, we encountered limited success in two cases where chronic thyroiditis had persisted for over ten years, suggesting that factors like fibrosis may influence treatment outcomes.
Overall, despite the small sample size, our findings challenge the idea that thyroid issues are perpetually autoimmune and irreversible, opening up new avenues for therapeutic options for patients with thyroid diseases.